Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
47
Views
7
CrossRef citations to date
0
Altmetric
Case Report

Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report

Sanghun Lee1 Department of Medical Consilience, Graduate School, Dankook University, Yongin, Republic of Korea
,
Jeonghyun Joo2 Department of Korean Internal Medicine, Comprehensive and Integrative Medicine Hospital, Daegu, Republic of Korea
,
Minah Kwak3 Department of Internal Medicine, College of Korean Medicine, Daegu Haany University, Daegu, Republic of Korea
,
Kicheul Sohn4 Department of Preventive Medicine, Daegu Catholic University Medical Center, Daegu, Republic of Korea
&
Songha Chon5 Department of Hemato-Oncology, Comprehensive and Integrative Medicine Hospital, Daegu, Republic of Korea, [email protected]Correspondence[email protected]
Pages 3943-3947 | Published online: 09 Jul 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christoforos Kosmidis, Georgios Koimtzis, Dimitrios Giannakidis, Nikos Tteralli, Stylianos Mantalovas, Alexandros Tsakalidis, Konstantina Tsopouridou, Stefanos Atmatzidis, Lazaros Liavas & Paul Zarogoulidis. (2019) Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients. International Medical Case Reports Journal 12, pages 15-20.
Read now

Articles from other publishers (6)

Gouji Toyokawa, Francesca Bersani, Paolo Bironzo, Francesca Picca, Fabrizio Tabbò, Naoki Haratake, Tomoyoshi Takenaka, Takashi Seto, Tomoharu Yoshizumi, Silvia Novello, Giorgio V. Scagliotti & Riccardo Taulli. (2023) Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. Critical Reviews in Oncology/Hematology 184, pages 103966.
Crossref
Akira Yamagata, Toshihide Yokoyama, Yasushi Fukuda & Tadashi Ishida. (2021) Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report. Respiratory Medicine Case Reports 33, pages 101440.
Crossref
Chi Pan, Huijie Duan, Yinan Wu, Chunpeng Zhu, Chenghao Yi, Yin Duan, Demin Lu, Cheng Guo, Deqi Wu, Yanyan Wang, Xianhua Fu, Jing Xu, Yiding Chen, Meng Luo, Wei Tian, Tao Pan, Wenhong Xu, Suzhan Zhang & Jianjin Huang. (2020) Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC. International Journal of Oncology.
Crossref
Ching-Fu Chang, Chih-We Wang & Cheng-Lung Hsu. (2020) A case of small-cell lung cancer harboring an epidermal growth factor receptor mutation that responded to epidermal growth factor receptor tyrosine kinase inhibitor treatment. Journal of Cancer Research and Practice 7:2, pages 78.
Crossref
Daniela Iacono, Giorgia A. Osman, Maria R. Migliorino, Lucia Grillo, Daniele Remotti, Josè Nunnari, Serena Ricciardi, Antonio Rossi, Andrea Mancuso, Paolo Graziano, Angela Di Lorenzo, Monica Bronzini, Mauro Signora & Alvaro Leone. (2019) Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients. American Journal of Clinical Oncology 42:11, pages 845-850.
Crossref
. (2018) Gefitinib. Reactions Weekly 1714:1, pages 201-201.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.